We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Toxin Implicated in Alzheimer's

By Biotechdaily staff writers
Posted on 29 Aug 2005
Researchers have discovered a toxin that plays an important role in the progression of Alzheimer's disease (AD). More...
Their finding was reported in the August 2005 issue of Neuropathology and Applied Neurobiology.

"We found that all of the brains of dementia patients showed quinolinic acid neurotoxicity,” explained Bruce Brew, professor of medicine at the University of New South Wales (UNSW, Sidney, Australia). "This acid kills nerve cells in the brain, leading to brain dysfunction and ultimately death.”

"Quinolinic acid is part of a biochemical pathway called the kynurenine pathway,” said lead author Dr. Gilles Guillemin, of the UNSW. "The activation of that pathway is also found in other major brain diseases, including Huntington's disease, stroke, dementia, and schizophrenia.”

The researchers noted that there are several drugs that can block this pathway and these are already under investigation. The drugs might be used to complement other treatments. The project was a collaboration involving scientists from the UNSW, the University of Sydney (Australia), and Hokkaido University (Japan).

"Quinolinic acid may not be the cause of Alzheimer's disease, but it plays a key role in its progression,” stated Dr. Karen Cullen, of the University of Sydney. "It's the smoking gun, if you like.”




Related Links:
University of New South Wales
U. of Sidney
Hokkaido U.

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Manual Pipetting Aid
Pipette Controllers macro
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.